S13, a rapidly oncogenic replication-defective avian retrovirus

Area of Science:

• Virology
• Molecular Biology
• Cancer Research

Background:

• Avian sarcoma and leukosis virus S13 (S13) is known to transform various cell types.
• Erythroid cell transformation by viruses often depends on specific culture conditions.
• Understanding viral oncogenesis is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the transformation capabilities of avian sarcoma and leukosis virus S13.
• To characterize the specific cellular targets and differentiation patterns induced by S13.
• To identify and analyze the viral proteins responsible for S13-induced transformation.

Main Methods:

• Tissue culture of chicken and Japanese quail embryo fibroblasts.
• Culture of chicken erythroid precursor cells under specific conditions.
• Analysis of viral protein synthesis and characterization using immunoprecipitation.

Main Results:

• S13 transforms chicken and Japanese quail embryo fibroblasts and chicken erythroid cells.
• S13-transformed erythroid cells differentiate without erythropoietin.
• S13 is defective in pol and env but produces gag proteins and a novel 155,000 MW protein.
• The 155,000 MW protein contains onc and env sequences but does not cross-react with v-erb A or v-erb B antisera.

Conclusions:

• Avian sarcoma and leukosis virus S13 induces erythroid differentiation through a novel mechanism.
• A unique 155,000 MW protein, linked to onc and env, is central to S13's transforming activity.
• This protein represents a new class of viral oncogenes distinct from previously identified erbA and erbB products.